Steven Gillis - Jun 17, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role: Director
Signature: /s/ Yalonda Howze, Attorney-in-Fact for Steven Gillis
Stock symbol: CDAKQ
Transactions as of: Jun 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/21/2022, 04:45 PM
Previous filing: Jun 17, 2022
Next filing: Sep 15, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDAKQ	Stock Option (Right to Buy)	Award	$0	+7.5K		$0.00	7.5K	Jun 17, 2022	Common Stock	7.5K	$2.83	Direct	F1
transaction	CDAKQ	Restricted Stock Units	Award	$0	+1.5K		$0.00	1.5K	Jun 17, 2022	Common Stock	1.5K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.